We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
416 47 0 MEDI
Emcee:  Larry Liebman Type:  Unmoderated
A frustrating stock with a compelling story....2 F.D.A. approved drugs...a deep pipeline...substantial cash...intriguing collaborations with HGSI and Rockerfeller University in bacterial research...recently broke ground on $50. million manufacturing facility...a sales force of 56...''buy'' recommendation from Morgan Stanley stating MEDI is the best buy in its' price range...and the stock languishes at $14....Company reports that it never has been in better shape...Worth a look...
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
416AstraZeneca initiates phase III immunotherapy study for MEDI4736 in patients witnigel bates-5/13/2014
415AstraZeneca announces MedImmune’s mavrilimumab and sifalimumab both met primary nigel bates-5/13/2014
414AstraZeneca to invest £330 Million in new strategic R&D centre and globnigel bates-3/18/2013
413New UK facility! Some much-needed good news for the UK: MedImmune has opened a nmlkr-10/20/2008
412AstraZeneca Sets MedImmune's Role By JEANNE WHALEN September 20, 2007; [WSJDoc Bones-9/20/2007
411MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among Hignigel bates-8/24/2007
410AstraZeneca Bid for Biotech Firm On Friday June 1, 9:32 am ET AstraZeneca Says sim1-6/1/2007
409Court dismisses attempt to hold up MedImmune merger Thursday May 31, 5:41 pm ET sim1-6/1/2007
408FDA Advisory Committee Recommends Expanded Use of FluMist(R) GAITHERSBURG, Md.,sim1-5/17/2007
407Astra confident of MedImmune deal despite lawsuit Wed May 16, 2007 5:22 AM ET Bsim1-5/16/2007
406MedImmune Aims for Wider FluMist Range By Robert Steyer Staff RepDoc Bones-5/15/2007
405Icahn scores lucrative victory in MedImmune sale Monday April 23, 5:43 pm ET By sim1-4/23/2007
404MedImmune Nears a Big Payday AstraZeneca Close to Deal That May Top $13 BillionDoc Bones-4/23/2007
403AstraZeneca PLC Near The Purchase Of MedImmune [Copied (filched) from another bsim1-4/23/2007
402Medimmune seems like it is doing fairly well---how many companies in the biotechMJ-4/13/2007
401Another article reg. same from Forbes------ forbes.comMJ-4/13/2007
400MedImmune Explores Strategic Alternatives GAITHERSBURG, Md., April 12 /PRNewswisim1-4/13/2007
399FluMist Maker MedImmune Mulls Sale of the Company By KEVIN KINGSBURY April 12, 2mopgcw-4/12/2007
398MedImmune Predicts Solid Quarterly Growth By CHRISTOPHER HINTON April 9, 2007 1Doc Bones-4/10/2007
397Another Stake in Biotech For Icahn Investor Buys 1.16% Of MedImmune By MichaelDoc Bones-2/17/2007
396MedImmune Heats Up By MOHAMMED HADI February 16, 2007; [WSJ] Page C7 Driven byDoc Bones-2/16/2007
395Flu Spray Most Effective for Children, Study Finds [NYT] <i>Interesting, Doc Bones-2/15/2007
394>>FDA Approves MedImmune's Refrigerated Formulation of FluMist(R) Mondtuck-1/8/2007
393MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With Bsjemmeri-12/19/2006
392MedImmune Completes Sale of CytoGam(R) GAITHERSBURG, Md., Dec. 18 /PRNewswire-Fsjemmeri-12/19/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):